Hamann MV, Beschorner N, Vu XK, Hauber I, Lange UC, Traenkle B, Kaiser PD, Foth D, Schneider C, Büning H, Rothbauer U, Hauber J (2021). Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors. PLoS One. 2021 Dec 20;16(12):e0261269.

Hamann MV, Ehmele P, Verdikt R, Bialek-Waldmann JK, Virdi S, Günther T, Van Lint C, Grundhoff A, Hauber J, Lange UC (2021). Transcriptional Behavior of the HIV-1 Promotor in Contect of the BACH2 Prominent Proviral Integration gene. Virus Res. 2021 Feb;293:198260.

Lange UC, Verdikt R, Ait-Ammar A, Van Lint C (2020). Epigenetic crosstalk in chronic infection with HIV-1. Semin Immunopathol. 2020 Apr;42(2):187-200.

Bialek JK, Walther T, Hauber J, Lange UC (2018). CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites. J Vis Exp. 2018 Nov 14;(141).

Lange UC, Bialek JK, Walther T, Hauber J (2018). Pinpointing recurrent proviral integration sites in new models for latent HIV-1 infection. Virus Res. 2018 Apr 2;249:69-75.

Bialek JK, Dunay GA, Voges M, Schäfer C, Spohn M, Stucka R, Hauber J, Lange UC (2016). Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems. PLoS One. 11:e0158294.

Karpinski J, Hauber I, Chemnitz J, Schäfer C, Paszkowski-Rogacz M, Chakraborty D, Beschorner N, Hofmann-Sieber H, Lange UC, Grundhoff A, Hackmann K, Schrock E, Abi-Ghanem J, Pisabarro MT, Surendranath V, Schambach A, {...} Hauber J, Buchholz F. (2016). Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity. Nat Biotechnol. 34:401-409.